REGISTER
OCC 2026 | Why Better Stents Matter
Dr. Fernando Alfonso recalls the early era of balloon angioplasty and coronary stents, when immediate procedural results looked excellent but some patients later returned with in-stent restenosis. For him, this clinical challenge showed why safer, better, and more durable cardiovascular devices remain essential for patients worldwide.

In OCC 2026 Quest for Truth roundtable, leading cardiovascular experts gather to discuss “Innovation: The Voyage Begins — From Chinese Stents to the Eastern Power in Global Cardiovascular Innovation”. The session is hosted by Prof. Gang Wu, Shanghai General Hospital, and co-moderated by Prof. Qixia Jiang, Shanghai General Hospital. Quest for Truth is honored to welcome the distinguished interview guest: Dr. Fernando Alfonso, Hospital Universitario de la Princesa.

In this segment, Prof. Gang Wu asks Dr. Fernando Alfonso to reflect on the early clinical challenges that shaped his belief in cardiovascular innovation. The question focuses on why better, safer, and more affordable devices are not merely technical ambitions, but real necessities for patients around the world.

Dr. Fernando Alfonso recalls the early era of balloon angioplasty and the arrival of coronary stents, which produced impressive immediate procedural results. However, he also remembers that some patients later returned with narrowing inside the stent, known as in-stent restenosis, showing that technical success in the catheterization lab did not always mean lasting clinical success.

For Dr. Alfonso, in-stent restenosis became a key reason to continue pursuing innovation. The experience showed that cardiovascular devices must not only deliver beautiful angiographic results, but also provide durable benefits for patients. Even today, he emphasizes, the search for definitive solutions remains an important mission in interventional cardiology.

0
0
Loading